Simulated microgravity induces a NOX-sensitive oxidative response that is attenuated by resveratrol in human endothelial cells Authors: Roberta Giordo, Claudia Sanna, Stefania Camboni, Paola Maccioccu, Alessia Manca, Antonella Pantaleo, Anna Maria Posadino, Gianfranco Pintus Published: 2026 ABSTRACT AbstractSpaceflight-associated microgravity perturbs endothelial physiology, at least in part, through oxidative stress and redox imbalance. Here, we investigated whether resveratrol protects human umbilical vein endothelial cells (HUVECs) exposed to simulated microgravity (µG) and examined whether an NADPH oxidase (NOX)-sensitive oxidative component contributes substantially to this response. Simulated µG significantly increased intracellular reactive oxygen species (ROS), enhanced protein carbonylation, disrupted glutathione homeostasis, and reduced cell viability. Pharmacological interrogation showed that diphenyleneiodonium (DPI), a broad inhibitor of flavin-dependent oxidases widely used to inhibit NOX activity, attenuated the oxidative response induced by µG. Resveratrol (1 µM) produced a comparable protective profile, reducing ROS accumulation, limiting oxidative protein damage, partially restoring the GSH/GSSG ratio, and preserving cell viability. In complementary assays, 2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo[1,2-a]pyrazin-3-one (MCLA) chemiluminescence, used here as a superoxide-associated readout, was increased under simulated µG and similarly reduced by both DPI and resveratrol. Given that NADPH oxidases (NOXs) are major endothelial sources of superoxide, the parallel inhibitory effects of DPI and resveratrol support the presence of a prominent NOX-sensitive, superoxide-associated component within the oxidative response induced by simulated µG. Collectively, these findings indicate that resveratrol attenuates simulated microgravity-induced oxidative stress and redox imbalance in endothelial cells and support its potential as a redox-active countermeasure under spaceflight-relevant conditions.Keywords: Resveratrol, Simulated microgravity, Oxidative stress, Endothelial cells, NADPH oxidase (NOX), Reactive oxygen species (ROS)Subject terms: Biochemistry, Cell biology, Diseases, Physiology Introduction During space missions, astronauts are exposed to environmental conditions that differ profoundly from those on Earth. Among these, microgravity (μG) represents one of the most disruptive stressors, as it profoundly affects human physiology by altering fundamental biological processes at both the cellular and tissue levels1,2. Exposure to μG has been associated with a wide range of adverse effects, including immune and endocrine dysregulation, skeletal muscle atrophy, bone demineralization, visual disturbances, and major structural and functional alterations of the cardiovascular system1,3. The cardiovascular system appears particularly vulnerable because spaceflight profoundly modifies systemic hemodynamics and fluid distribution4,5. In addition, concomitant exposure to space radiation may further aggravate cardiovascular risk by promoting vascular remodeling, fibrosis, and arterial dysfunction5–9. Within the vascular system, endothelial cells (ECs) are especially relevant because they are central regulators of vascular homeostasis, blood flow, inflammatory signaling, and barrier integrity10. A growing body of evidence indicates that ECs are highly sensitive to μG, which induces broad molecular and functional alterations, including changes in the expression of inflammatory mediators and adhesion molecules, together with impairment of proliferation, migration, apoptosis, and angiogenesis11–13. These endothelial alterations are not merely transient cellular responses, but may contribute to vascular impairment, microcirculatory dysfunction, and cardiovascular deconditioning during spaceflight14,15. Moreover, endothelial remodeling and barrier dysfunction under μG conditions may have longer-term consequences for cardiovascular health, thereby reinforcing the need to identify effective countermeasures against spaceflight-associated vascular injury14–16. One of the most important mechanistic drivers of endothelial dysfunction is oxidative stress, which arises from excessive reactive oxygen species (ROS) production and/or insufficient antioxidant defense capacity17. ROS overaccumulation can damage key macromolecular targets, including membranes, proteins, lipids, and nucleic acids, thereby interfering with DNA replication, transcription, repair, and protein synthesis18. In this context, both in vivo and in vitro studies, using either space-flown samples or ground-based simulators, have consistently identified oxidative stress as a major contributor to μG-induced cellular dysfunction19–23. Indeed, substantial evidence indicates that simulated microgravity perturbs endothelial homeostasis and promotes pro-oxidant and inflammatory stress responses in endothelial and other vascular cell models24–29. However, despite these advances, several mechanistic aspects remain insufficiently resolved. Representative studies have described endothelial apoptosis, altered angiogenic behavior, increased monolayer permeability, endoplasmic reticulum stress associated with iNOS/NO–NF-κB/NLRP3 activation, mitochondrial remodeling and mitophagy, as well as ROS/mtROS-related dysfunction under simulated microgravity24–29. Nevertheless, these endpoints have generally been investigated separately rather than within an integrated redox framework in the same endothelial model. Moreover, although NADPH oxidases (NOXs) have been implicated in vascular oxidative stress under unloading conditions, including hindlimb-unweighting models showing increased vascular NOX activity or expression together with partial functional rescue by apocynin30,31, direct pharmacological interrogation of a NOX-sensitive oxidative component in simulated microgravity-exposed endothelial cells remains limited. Likewise, although post-microgravity readaptation effects after return to normal gravity have been described in HUVECs32,33, the persistence of oxidative imbalance per se during gravitational recovery remains insufficiently characterized. Thus, a coherent redox framework linking intracellular ROS accumulation, glutathione disequilibrium, oxidative protein damage, superoxide- and redox-sensitive signaling, and endothelial functional impairment under simulated microgravity is still lacking24,26,27,29,32–34. Natural antioxidants have attracted growing interest as modulators of vascular redox imbalance and endothelial injury35–38. Among them, resveratrol (3,5,4′-trihydroxystilbene), a polyphenolic compound abundant in grapes and red wine, has emerged as a particularly promising candidate because of its cardioprotective, neuroprotective, anti-inflammatory, anticarcinogenic, and antioxidant properties39–42. Its antioxidant activity involves both direct ROS scavenging and indirect modulation of redox-sensitive signaling pathways, together with enhancement of endogenous antioxidant defenses43. Preclinical and clinical studies have shown that resveratrol can improve endothelial function, especially in patients with metabolic syndrome, diabetes, hypertension, or hypercholesterolemia, through mechanisms involving nitric oxide enhancement, suppression of inflammation, and attenuation of oxidative stress44–47. However, although antioxidant-based strategies have been investigated in microgravity-related oxidative stress19–23 and natural antioxidants have shown protective effects in endothelial injury models35–38, these studies have mainly focused on global redox imbalance and downstream oxidative damage rather than on a defined enzymatic source of ROS. In this context, the potential of resveratrol to attenuate a NOX-sensitive oxidative component in endothelial cells under simulated microgravity remains to be established. In the present study, using human umbilical vein endothelial cells (HUVECs) as an in vitro endothelial model48, we investigated whether resveratrol mitigates simulated μG-induced endothelial oxidative stress and whether a prominent NOX-sensitive, superoxide-associated component contributes substantially to this response, by assessing intracellular ROS accumulation, glutathione redox balance, protein carbonylation, superoxide-associated chemiluminescence, and viable cell number after 24 h of exposure. Our data show that simulated μG induces a marked oxidative shift, characterized by increased ROS levels, glutathione imbalance, protein oxidation, and reduced viable cell number, all of which were significantly attenuated by resveratrol. Importantly, both diphenyleneiodonium (DPI) and resveratrol blunted the 2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo[1,2-a]pyrazin-3-one (MCLA)-detectable superoxide-associated signal, supporting the presence of a prominent NOX-sensitive oxidative component and raising the possibility that resveratrol attenuates this NOX-sensitive component either by limiting NOX-linked superoxide generation or by modulating convergent redox mechanisms under simulated μG. Materials and methods Cell culture and treatment Human umbilical vein endothelial cells (HUVECs) were purchased as cryopreserved primary cells from PromoCell (Heidelberg, Germany) and cultured according to previously described protocols49,50. After thawing, cells were plated in T25 culture flasks in endothelial cell basal medium supplemented with the Endothelial Cell Growth Medium MV Supplement Mix (C-39225) according to the manufacturer’s instructions. Following plating, the cells corresponded to passage 1 and typically reached approximately 90% confluence within about 24 h under the culture conditions recommended by the manufacturer’s instructions (see link C-12221). Cells were then subcultured to generate passage 2, and from this stage onward were expanded and used for experiments up to a maximum of passage 4. HUVECs were treated with 1 µM resveratrol, administered 24 h before and maintained throughout the 24-h clinorotation exposure, or with 5 µM diphenyleneiodonium (DPI), administered 1 h before clinorotation. The different pretreatment schedules reflected the distinct experimental roles and expected modes of action of the two compounds. DPI was used as an acute pharmacological probe of NOX/NADPH oxidase-sensitive oxidant signaling, consistent with recent studies using diphenyleneiodonium chloride to inhibit NOX-associated cellular responses, while recognizing that DPI is a broad flavoprotein inhibitor rather than a NOX-selective compound51,52. By contrast, resveratrol was administered using a longer pretreatment schedule because its endothelial actions may involve both direct redox-active effects and modulation of redox-sensitive signaling pathways and endogenous antioxidant defenses. The concentrations and schedules were selected on the basis of previous endothelial redox studies and our prior experimental experience with resveratrol and DPI in endothelial cell models39,40,49,50,53,54. All reagents were purchased from Sigma-Aldrich. Cell counting Cell counting was performed using the trypan blue exclusion test. This test is based on the principle that the dye cannot penetrate the intact membranes of viable cells, whereas it can enter dead cells, staining them blue and thus making them quantifiable55. To perform the cell count, 10 μL of the HUVEC cells suspension was mixed with 10 μL of Trypan Blue (TB) (Invitrogen) and loaded into the chamber of LUNA™ Cell Counting Slide. Cell number, expressed as cell number/ml, was then counted by inserting the slide into LUNA Automated Cell Counter (Invitrogen). Microgravity simulation To assess the potential impact of μG conditions on HUVECs, experiments were performed using a 3D random positioning machine (RPM, Fokker Space, Netherlands) at the laboratory of the Department of Biomedical Sciences of the University of Sassari. This device is a ground-based simulator composed of two perpendicular frames that independently rotate changing the direction of the gravity vector to achieve a gravity reduction. The 3D RPM simulates a μG lower than 10−3 g and it is connected to a computer to select the mode and speed of rotation. The random Walk mode at 80 degrees/s was used56,57. For μG exposure, HUVECs were cultured in a 12.5 cm2 flask, that was carefully filled with M199 medium supplemented with 10% (v/v) fetal calf serum (FCS), 10% (v/v) newborn calf serum, 2 mM glutamine, antibiotics and 15 mM HEPES, without air bubbles to avoid fluid shear. Cells used as controls have been placed in the static bar at 1 g to undergo the same vibration as the sample in μG conditions. Protein extraction After treatment, cells were washed with chilled PBS and incubated in ice-cold 50 mM MES (2-N-morpholino ethanesulfonic acid) containing 1 mM EDTA, and protease/phosphatase inhibitors, for 10 min at 4 °C. Cells were then scraped, and the lysate was centrifuged at 10,000 × g for 15 min at 4 °C. The supernatant was collected and stored at − 80 °C. Protein concentration was determined using a NanoDrop spectrophotometer and/or the Bradford assay, according to the manufacturer’s instructions (Sigma, St. Louis, MO, USA).. Intracellular ROS levels measurement Intracellular ROS levels were measured using the cell-permeant probe 2’,7'-dichlorodihydrofluorescein diacetate (H2DCFDA; Molecular Probes, Eugene, OR, USA), a widely used indicator of intracellular ROS production58,59. After deacetylation by intracellular esterases, H2DCFDA is oxidized in the presence of ROS to yield a fluorescent product; thus, increased fluorescence reflects higher intracellular ROS levels. After 24 h of simulated μG exposure, HUVECs were incubated for 30 min in Hanks’ balanced salt solution (HBSS) containing 10 µM H2DCFDA and then washed with phosphate-buffered saline (PBS). Because simulated μG may affect HUVEC proliferation and, consequently, cell density and total cellular biomass, fluorescence data were evaluated using two normalization approaches within the same assay. Cells were first trypsinized and counted, allowing fluorescence values to be normalized to cell number. The same cell samples were then lysed in RIPA buffer (500 μL per 12.5 cm2 flask) on ice for 5 min. Lysates were collected into 1.5 mL tubes and centrifuged at 50,000 × g for 10 min at 4 °C. The supernatants were transferred to black 96-well clear-bottom plates, and fluorescence was measured using a GENios Plus microplate reader (Tecan, Männedorf, Switzerland) at 485 nm excitation and 535 nm emission. Fluorescence values were corrected for background and normalized to total protein content, expressed as mg/mL, following protein quantification. The two normalization methods yielded comparable results; the data shown in Figs. 1 and 2 are normalized to total protein content. Results were obtained from five independent experiments and are expressed as mean ± standard deviation (SD) of relative fluorescence units (RFU)58,59. Simulated microgravity induces intracellular ROS accumulation in HUVECs and this effect persists after return to normal gravity. (A) HUVECs were exposed to simulated microgravity (μG) for 24 h using a random positioning machine. Intracellular ROS levels were significantly higher in μG-exposed cells than in cells maintained under normal gravity (G). (B) HUVECs were exposed to simulated microgravity (μG) for 24 h and then returned to normal gravity (G) for an additional 24 h. ROS levels remained significantly elevated after reconditioning compared with gravity controls. ROS levels are expressed as relative fluorescence units (RFUs), corrected for background fluorescence and normalized to protein content (mg/mL). Statistical significance was assessed using an unpaired t-test: (A) p = 0.0003; (B) p < 0.0001. Resveratrol attenuates microgravity-induced ROS accumulation in HUVECs. Intracellular ROS levels were measured after 24 h exposure to simulated microgravity (μG) or normal gravity (G), in the presence or absence of 1 µM resveratrol (RES). Groups were defined as follows: μG = simulated microgravity; μG + RES = simulated microgravity with resveratrol; G = normal gravity; G + RES = normal gravity with resveratrol. Simulated microgravity significantly increased intracellular ROS levels, and resveratrol significantly reduced this increase. However, ROS levels in the μG + RES group remained significantly higher than those in the G group, indicating partial rather than complete normalization. No significant difference was observed between G and G + RES. Data are expressed as mean ± SD. Statistical analysis was performed using one-way repeated-measures ANOVA followed by Tukey’s post hoc test; p < 0.05 was considered significant. Glutathione quantification Glutathione levels were determined using a fluorometric assay kit (BioVision, Abcam, Waltham, MA, USA), which allows the quantification of reduced (GSH), oxidized (GSSG) and total glutathione50. The assay is based on the reaction of O-phthalaldehyde (OPA) with GSH, which produces a fluorescent signal measurable at Ex/Em = 340/420 nm. To selectively measure GSSG, free GSH in the samples was first masked by adding a GSH quencher that prevents its reaction with OPA. A reducing agent was then added to convert GSSG to GSH for quantification. In parallel, total glutathione (GSH + GSSG) and GSH alone were determined in separate reactions, using freshly prepared GSH standard curves on each 96-well plate. Both standards and samples were read with a fluorescence plate reader equipped with Ex/Em = 340/420 nm (GENios Plus-Tecan). After simulated μG exposure, cell lysates were prepared and protein concentrations were determined as described in section "Protein extraction". For each sample, fluorescence values obtained for GSH and GSSG were background-corrected and normalized to total protein content. The cellular redox status was then expressed as the GSH/GSSG ratio, calculated by dividing the normalized GSH value by the normalized GSSG value. Results are expressed as mean ± SD from three independent experiments. Protein carbonyl content measurement Protein carbonyl (PC) content is the most commonly used marker of protein oxidation, which is known to be a consequence of free radical production60. Redox cations can bind to cation binding locations on proteins and, along with further attack by H2O2 or O2, can modify side-chain amine groups on several amino acids (i.e. lysine, histidine, proline or arginine) into carbonyls. The most convenient method to detect and measure carbonyl content is the reaction between protein carbonyls and 2,4-dinitrophenylhydrazine (DNPH), which produces a protein-DNP hydrazone moiety that can be detected spectrophotometrically. In this work, the dinitrophenylhydrazine (DNPH) reaction-based assay kit (Protein Carbonyl Assay Kit, Cayman chemical) was used55,61. Following μG exposure, cells were collected by centrifugation at 1400× g for 10 min at 4 °C. The cells pellet was then homogenized on ice in 1 ml of 50 mM MES containing 1 mM EDTA, and protease/phosphatase inhibitors, and protein content was extracted as described in section "Protein extraction". The protein carbonyl content assay was then performed as follows, 200 μL of sample were transferred into two 2 ml plastic tubes, one tube for the sample (S) and the other for the control (C). 800 μL of DNPH were added to the sample tube, while 800 μL of 2.5 M HCl were added to the control. Both tubes were incubated in the dark at room temperature for one hour, vortexing them every 15 min. After incubation, 1 ml of 20% trichloroacetic acid (TCA) was added to each tube, and incubated in ice for 5 min. Tubes were then centrifuged at 10,000 × g for 10 min at 4 °C. After centrifugation, the pellet was resuspended in 1 ml of 10% TCA, and placed on ice for 5 min. An additional centrifugation step at 10,000 × g for 10 min at 4 °C was then performed. At this point, pellet was washed with 1 ml of (1:1) ethanol/ethyl acetate, tubes were vortexed thoroughly and centrifuged at 10,000 × g for 10 min at 4 °C. This step was repeated two more times. After the final wash, the protein pellet was resuspended in 500 μL of guanidine hydrochloride by vortexing. A final centrifugation was then performed in order to remove any leftover debris. Finally, 220 μL of supernatant from the sample tube and 220 μL of supernatant from the control tube were transferred into to a 96-well plate, and the absorbance was read at a wavelength between 360 and 385 nm in a microplate reader (GENios plus-Tecan)55,61. The corrected absorbance (CA) was then determined by subtracting the average absorbance of the controls from the average absorbance of the samples. Finally, the carbonyl concentration was calculated by inserting the CA in the following equation: The total protein content in each sample was quantified using a NanoDrop spectrophotometer and used to normalize the corresponding absorbance measurements within each individual experiment. Accordingly, carbonyl content was standardized to protein concentration and reported as nmol/mg protein. MCLA assay The highly sensitive chemiluminescent probe MCLA (Methoxylated Cypridina Luciferin Analog; MERCK) was used to assess a superoxide-associated chemiluminescence signal62–64. Upon reacting with superoxide anions, this probe emits blue luminescence (~ 455 nm). The MCLA-detectable superoxide-associated signal was assessed in HUVECs following 24-h exposure to simulated μG. Cells were harvested and washed twice with ice-cold phosphate-buffered saline (PBS). The cell pellet was resuspended in ice-cold lysis buffer containing 20 mM HEPES (pH 7.2), 1 mM EGTA, 150 mM NaCl, 1 mM MgCl₂, 1 mM DTT, and a protease inhibitor cocktail (without EDTA). To preserve membrane-bound NADPH oxidase activity, cells were lysed by gentle homogenization using a Dounce homogenizer (15–20 strokes on ice). The homogenate was centrifuged at 1000 × g for 10 min at 4 °C to remove unbroken cells and nuclei. The resulting supernatant was further centrifuged at 10,000 × g for 20 min at 4 °C to obtain a membrane-enriched fraction. Protein concentration was determined using the Bradford assay. NADPH-dependent superoxide-associated chemiluminescence was measured using the probe MCLA as an operational readout of flavin/NOX-sensitive oxidant activity. The assay was conducted in white 96-well plates. Each well contained 50 µg of membrane protein from the membrane-enriched fraction in reaction buffer (50 mM HEPES, pH 7.0, 1 mM EGTA, 150 mM NaCl, 1 mM MgCl₂), 5 µM MCLA, and 100 µM NADPH, in a final volume of 200 µL. Chemiluminescence was measured immediately at 37 °C using a GENios Plus microplate reader (Tecan, Männedorf, Switzerland), with readings taken every 30 s for up to 30 min. Results were expressed as relative chemiluminescence units (RCU) per second. For quantitative comparison among groups, the value shown in Fig. 6 corresponds to the maximal background-corrected MCLA chemiluminescence recorded at 5 min. Because the same amount of membrane protein was loaded in each well, comparability across samples was achieved by equal protein input. DPI and resveratrol attenuate the superoxide-associated MCLA signal induced by simulated microgravity in HUVECs. HUVECs were exposed to simulated microgravity (µG) or normal gravity (G) for 24 h, with or without pre-treatment with 5 µM diphenyleneiodonium (DPI, 1 h) or 1 µM resveratrol (RES). Groups are defined as follows: µG = simulated microgravity; µG + DPI = µG with DPI pre-treatment; µG + RES = µG with resveratrol; G = normal gravity; G + DPI = normal gravity with DPI; G + RES = normal gravity with resveratrol. PMA-stimulated samples are shown separately and were included only as an assay-validating positive-control condition to verify responsiveness of the MCLA system; they were not part of the main gravitational/treatment comparison groups65–67. The superoxide-associated signal was assessed using the chemiluminescent probe MCLA. Results are expressed as background-corrected relative chemiluminescence units (RCU) per second obtained with equal loading of 50 µg membrane protein per well. The bar graph shows the maximal MCLA luminescence recorded at 5 min. Data represent the mean ± SD of four independent measurements. Statistical differences were considered significant at p < 0.05. Background luminescence was assessed in wells without NADPH. As a positive control for superoxide production, phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich), an inducer of NADPH oxidase, was used65–67. Cell lysates were stimulated with 100 nM PMA and incubated for 10 min at 37 °C prior to the addition of 5 µM MCLA. To support the contribution of a DPI-sensitive flavin-dependent oxidase component to the MCLA signal, control reactions were performed in the presence of 5 µM DPI, a flavoprotein inhibitor. A reduction in luminescence under these conditions supported the presence of a NOX-sensitive superoxide-associated component, although this pharmacological approach does not exclude contributions from other DPI-sensitive oxidant sources. Statistical analysis Data are expressed as mean ± standard deviation (SD). Differences between two groups were analyzed using an unpaired t-test. Comparisons among more than two groups were performed using a one-way repeated-measures ANOVA followed by Tukey’s post hoc multiple comparisons test. A p-value < 0.05 was considered statistically significant. All statistical analyses were performed using GraphPad Prism version 9.00 for Windows (GraphPad Software, San Diego, CA, USA). Results Simulated microgravity triggers sustained ROS elevation in endothelial cells ROS are molecules produced as natural byproducts of cellular metabolism68. While they play essential roles in physiological processes such as cell signaling, inflammation, proliferation, aging, and programmed cell death68, excessive ROS accumulation—resulting from an imbalance between production and antioxidant defenses—can lead to oxidative stress69. Due to their high reactivity, ROS readily interact with macromolecules like proteins, lipids, and DNA, contributing to cellular dysfunction and the onset of various pathologies68,69. In particular, elevated ROS levels have been shown to induce metabolic and morphological alterations in the cardiovascular system and to impair key cell types such as endothelial cells17,70,71, which in turn can further amplify ROS production and exacerbate oxidative stress72. Oxidative stress is recognized as one of the major cellular responses to μG exposure73. To investigate this phenomenon, we exposed HUVECs to simulated μG for 24 h using a 3D random positioning machine (RPM). As shown in Fig. 1A, ROS levels were significantly increased under μG conditions (μG) compared to cells cultured under normal gravity (G) (p = 0.0003), confirming that oxidative stress is an early response to altered gravitational environments. Importantly, when cells were returned to normal gravity conditions for an additional 24 h following μG exposure, ROS levels remained significantly elevated (Fig. 1B, p < 0.0001), indicating that the oxidative imbalance persists even after re-exposure to standard gravity. Together, these findings suggest that while endothelial cells may attempt to adapt to gravitational changes, the oxidative damage induced by μG is not readily reversible. This persistent redox imbalance may compromise endothelial functionality and contribute to broader physiological dysregulations during and after spaceflight. Resveratrol counteracts microgravity-induced ROS generation Resveratrol is well known for its antioxidant properties, which are mediated both by its ability to directly scavenge ROS and by its capacity to enhance endogenous antioxidant defenses through the upregulation of detoxifying enzymes43,74. To evaluate whether resveratrol can mitigate oxidative stress triggered by μG, HUVECs were treated with 1 μM resveratrol 24 h prior to and throughout the 24-h exposure to simulated μG. As shown in Fig. 2, exposure to μG resulted in a significant increase in intracellular ROS levels compared with normal gravity conditions (G) (p < 0.0001). Resveratrol treatment significantly attenuated this ROS accumulation (μG vs μG + RES, p = 0.0006). However, ROS levels in the μG + RES group remained significantly higher than those measured under normal gravity (μG + RES vs G, p = 0.0027), indicating only a partial recovery. No significant difference was observed between G and G + RES, indicating that resveratrol did not exert a measurable effect on basal ROS levels under normogravity. These results indicate that resveratrol significantly attenuates, but does not completely reverse, the increase in intracellular ROS induced by simulated μG in endothelial cells. Resveratrol preserves the GSH/GSSG redox balance under simulated microgravity Glutathione represents one of the major intracellular antioxidant systems, crucial for maintaining redox homeostasis and protecting endothelial cells from ROS–induced damage75–78. This tripeptide (γ-glutamyl-cysteinyl-glycine) contains a reactive thiol (–SH) group that participates in the direct detoxification of reactive species and supports enzymatic defenses such as glutathione peroxidase and glutathione reductase75–79. The ratio between the reduced (GSH) and oxidized (GSSG) forms of glutathione is widely recognized as a sensitive index of the cellular redox state80,81. To determine whether short-term simulated μG perturbs endothelial redox homeostasis, and to assess the protective potential of resveratrol, we quantified intracellular GSH and GSSG levels after 24 h of exposure. As shown in Fig. 3, μG exposure caused a marked reduction in the GSH/GSSG ratio compared with the 1 g control (μG vs G, p = 0.0010), indicating a shift toward a more oxidized intracellular environment due to depletion of reduced glutathione. Resveratrol partially restores the GSH/GSSG ratio disrupted by simulated microgravity in HUVECs. HUVECs were cultured for 24 h under normal gravity (G) or simulated microgravity (μG), in the absence or presence of 1 µM resveratrol (RES). Experimental groups: G = normal gravity; G + RES = normal gravity with resveratrol; μG = simulated microgravity; μG + RES = simulated microgravity with resveratrol. The intracellular redox state was assessed by quantifying reduced (GSH) and oxidized (GSSG) glutathione using a fluorometric assay. For each sample, GSH and GSSG fluorescence values were background-corrected and normalized to total protein content, and the GSH/GSSG ratio was then calculated from the corresponding normalized values. Data are expressed as mean ± SD (n = 3 independent experiments). Statistical significance was determined by one-way repeated-measures ANOVA followed by Tukey’s post hoc test; p < 0.05 was considered significant. Treatment with 1 µM resveratrol under μG conditions (μG + RES) partially restored the GSH/GSSG ratio, showing a significant increase compared with untreated μG-exposed cells (μG vs μG + RES, p = 0.0411). Nevertheless, the ratio in resveratrol-treated μG cells remained lower than in normogravity controls, suggesting only partial recovery of redox balance. In contrast, resveratrol had no appreciable effect on the GSH/GSSG ratio in cells maintained under 1 g conditions, indicating that its antioxidant action is specifically triggered by μG-induced oxidative stress. Overall, these findings demonstrate that simulated μG compromises endothelial redox homeostasis by promoting glutathione oxidation, and that resveratrol mitigates this effect by preserving the pool of reduced glutathione and restoring, at least in part, the physiological GSH/GSSG equilibrium. Resveratrol counteracts protein carbonylation caused by microgravity exposure As previously demonstrated, simulated μG induces a redox imbalance characterized by elevated ROS production and glutathione oxidation. In this oxidative environment, proteins are among the primary molecular targets. ROS can oxidize amino acid side chains directly or indirectly via reactive lipid or carbohydrate byproducts, leading to the formation of carbonyl (CO) groups on proteins55,82. These carbonyl derivatives represent well-established biomarkers of irreversible oxidative protein damage83,84. To further assess oxidative stress in our model, we quantified protein carbonyl content in HUVEC lysates using the DNPH (2,4-dinitrophenylhydrazine) derivatization method, according to Levine et al.85. This approach allows for spectrophotometric detection of DNP-hydrazone adducts as an indicator of total protein carbonylation86. As shown in Fig. 4, exposure to simulated μG for 24 h resulted in a significant increase in protein carbonylation compared to cells maintained under normal gravity (μG vs G, p = 0.0043), confirming a condition of sustained oxidative stress. Notably, resveratrol treatment significantly reduced protein carbonyl content in μG-exposed cells (μG vs μG + RES, p = 0.0316), demonstrating its efficacy in limiting protein oxidation. Importantly, resveratrol had no pro-oxidant effect under normogravity (G vs G + RES, p = 0.1953), consistent with its redox-buffering role. Resveratrol reduces protein carbonylation induced by simulated microgravity in HUVECs. Cells were cultured under normal gravity (G) or simulated microgravity (μG), with or without 1 μM resveratrol (RES). Experimental groups are as follows: μG = microgravity; μG + RES = microgravity with resveratrol; G = normal gravity; G + RES = normal gravity with resveratrol. Protein carbonyl content was quantified spectrophotometrically after DNPH derivatization and is expressed as nmol/mg protein. Data represent mean ± SD. Statistical analysis was performed using one-way repeated-measures ANOVA followed by Tukey’s post hoc test. p < 0.05 was considered statistically significant. Together with the observed reduction in ROS levels (Fig. 2) and partial restoration of the GSH/GSSG ratio (Fig. 3), these data provide strong evidence that resveratrol protects endothelial cells against μG-induced oxidative protein damage, likely through both direct scavenging activity and modulation of redox signaling pathways. Simulated microgravity induces a NOX-sensitive oxidative response that is attenuated by DPI and resveratrol NADPH oxidases (NOXs) are major enzymatic sources of ROS in endothelial cells, and NOX4 is reported to be among the most abundant isoforms in HUVECs87–89. These membrane-associated enzymes can be activated by multiple stimuli, including cytokines, growth factors, shear stress, and mechanical cues, and their dysregulation has been linked to oxidative stress in several tissues87–89. Previous studies have also suggested that real and simulated microgravity may enhance NOX-associated ROS production in different biological systems, including cardiovascular and immune cells23,30,31,73. To investigate whether a NOX-sensitive oxidant system contributes to the oxidative response induced by simulated μG, HUVECs were pre-treated with 5 μM DPI, a broad inhibitor of flavin-dependent oxidases widely used to inhibit NOX activity39,40,49,50,54, prior to 24-h clinorotation. As shown in Fig. 5, DPI markedly attenuated the increase in intracellular ROS triggered by simulated μG, indicating that a DPI-sensitive oxidant source contributes substantially to the microgravity-associated ROS surge. To further interrogate the superoxide-associated component of this signal, we next assessed MCLA chemiluminescence, a highly sensitive superoxide-associated readout62–64. After 24 h of simulated μG, HUVECs exhibited a significant increase in the MCLA-detectable signal, which was attenuated by both DPI and resveratrol (Fig. 6). Given that endothelial NOX enzymes are major sources of vascular superoxide/ROS87–89, the MCLA signal detected under our experimental conditions is consistent with NOX-associated superoxide production. This interpretation is further supported by the responsiveness of our system to PMA, which was included as a separate assay-validating positive-control condition and is a well-established activator of endothelial NOX-dependent superoxide production90,91, whose effects in endothelial cells depend critically on p47phox-mediated NADPH oxidase activation and have previously been reported to be inhibited by resveratrol39,92,93. Accordingly, although DPI is a broad inhibitor of flavin-containing oxidases, its marked suppression of the MCLA signal supports a major NOX-sensitive contribution to superoxide-associated chemiluminescence in this setting, while not excluding other flavin-dependent or mitochondrial oxidant sources. The similar inhibitory effect exerted by resveratrol is therefore consistent with the possibility that this polyphenol attenuates a NOX-sensitive oxidative component, either by interfering with NOX-related superoxide generation or by modulating upstream and downstream redox mechanisms that converge on the same superoxide-associated readout. These data are in line with previous evidence showing that resveratrol attenuates endothelial oxidative stress, at least in part, through inhibition of NOX activity and/or downregulation of NOX subunits39,92,93. DPI attenuates intracellular ROS accumulation induced by simulated microgravity in HUVECs. HUVECs were exposed to simulated microgravity (μG) or maintained under normal gravity (G), with or without pre-treatment with diphenyleneiodonium (DPI) (5 μM, 1 h), a broad inhibitor of flavin-dependent oxidases. Experimental groups: μG = simulated microgravity; μG + DPI = μG with DPI pre-treatment; G = normal gravity; G + DPI = normal gravity with DPI pre-treatment. Intracellular ROS levels were quantified using a fluorescence-based assay and expressed as relative fluorescence units (RFUs), normalized to background and total protein content (mg/mL). Data represent mean ± SD from four independent replicates. Statistical significance was assessed using one-way repeated-measures ANOVA with Tukey’s post hoc test; p < 0.05 was considered significant. Collectively, these findings support the presence of a prominent NOX-sensitive, superoxide-associated component under simulated μG, while not proving an exclusive NOX origin or identifying a specific NOX isoform. They also indicate that resveratrol attenuates this component in a manner compatible with, but not limited to, modulation of NOX-linked oxidant signaling. DPI and resveratrol mitigate the redox-associated reduction in viable cell number induced by microgravity As mentioned earlier, endothelial cells are particularly sensitive to μG, undergoing molecular and functional alterations that impair key processes such as proliferation, migration, and apoptosis32,33,94,95. These changes can culminate in endothelial dysfunction, a hallmark of cardiovascular pathologies11,32,33. A substantial body of evidence implicates ROS as major contributors to these effects, given their role in modulating mitochondrial function, promoting the release of pro-apoptotic factors, and activating stress-related signaling pathways that ultimately impair cell viability and proliferation17,68,79,96. To determine whether simulated μG impairs endothelial proliferation through a redox-sensitive mechanism linked to the oxidant pathway described above, HUVECs were pre-treated with 5 μM DPI, a broad flavoprotein inhibitor widely used to inhibit NOX activity51,52, or with 1 μM resveratrol, administered 24 h before and maintained throughout the 24-h clinorotation period39,40,49,50,54. As shown in Fig. 7, μG exposure led to a marked reduction in cell density and confluence, consistent with decreased proliferation. However, this effect was significantly counteracted by both DPI and resveratrol, which preserved cell morphology and monolayer integrity. These qualitative observations were supported by quantitative results from the trypan blue exclusion assay (Fig. 8, which confirmed a significant decrease in viable cell numbers under µG that was significantly mitigated by either treatment. In addition, both DPI and resveratrol significantly increased cell number under 1G conditions (G vs G + DPI, p = 0.0199; G vs G + RES, p = 0.0034. Resveratrol and DPI preserve HUVEC morphology and cell density under simulated microgravity conditions. Representative phase-contrast microscopy images of HUVECs after 24-h exposure to simulated microgravity (μG) or normal gravity (G), with or without treatment. Groups are defined as follows: µG = cells exposed to simulated microgravity; µG + DPI = cells pre-treated with 5 μM diphenyleneiodonium (DPI) before microgravity exposure; µG + RES = cells treated with 1 μM resveratrol during microgravity exposure; G = control cells under normal gravity; G + DPI = control cells under normal gravity pre-treated with DPI; G + RES = control cells under normal gravity treated with resveratrol. Both DPI and resveratrol preserved cell density and morphology comparable to normal gravity conditions, counteracting the reduction in cell density induced by μG. DPI and resveratrol mitigate the reduction in HUVEC viability induced by simulated microgravity and increase cell number under normogravity. Quantification of viable HUVECs by trypan blue exclusion assay after 24-h exposure to simulated microgravity (µG) or normal gravity (G), in the absence or presence of diphenyleneiodonium (DPI) or resveratrol. Groups are defined as follows: µG = cells exposed to simulated microgravity; µG + DPI = cells pre-treated with 5 µM DPI; µG + RES = cells treated with 1 µM resveratrol; G = control cells under normal gravity; G + DPI = control cells pre-treated with DPI; G + RES = control cells treated with resveratrol. Both DPI and resveratrol significantly attenuated the loss of viable cells under µG and also significantly increased cell number under 1G conditions. Data represent mean ± SD from four independent experiments. Statistical significance was assessed by one-way repeated-measures ANOVA followed by Tukey’s post hoc test; p < 0.05 was considered significant. These findings support the view that oxidative stress is a key mediator of the antiproliferative effects induced by μG and are consistent with a substantial contribution of a NOX-sensitive redox component to this response. Although both DPI and resveratrol also produced a modest but significant increase in cell number under 1G conditions, their ability to mitigate the loss of viable cells under µG strongly supports a model in which microgravity promotes ROS accumulation, redox imbalance, and downstream functional impairment73,97. Thus, targeting a NOX-sensitive oxidant source and/or its downstream oxidative consequences may represent a viable strategy to preserve endothelial redox homeostasis under altered gravitational conditions. Discussion Adequate nutritional support, in synergy with targeted medical interventions, plays a vital role in safeguarding astronaut health during space missions by counteracting μG-induced physiological stressors. Among these, endothelial dysfunction represents an early and critical event in cardiovascular impairment11–13,19,32,33,94. In this context, resveratrol—a dietary polyphenol with well-established antioxidant, anti-inflammatory, and cardioprotective properties—emerges as a promising candidate for countermeasures in space biology98,99. This study provides two main insights into the cellular response of endothelial cells to simulated μG. First, our data support the presence of a prominent NOX-sensitive oxidative component within the broader redox disturbance induced by μG. Second, we show that resveratrol attenuates μG-induced oxidative damage, partially restores redox homeostasis, and limits the downstream reduction in viable cell number, consistent with attenuation of a NOX-sensitive oxidative component while not excluding additional antioxidant or mitochondrial mechanisms. Using HUVECs, a well-established in vitro model for vascular biology48, we found that 24-h exposure to simulated μG disrupts redox homeostasis and reduces cell number. Specifically, μG increased intracellular ROS (Figs. 1, 2), decreased the GSH/GSSG ratio (Fig. 3), enhanced protein carbonylation (Fig. 4), and led to a significant loss of viable cells (Figs. 7, 8)—hallmarks of oxidative stress and endothelial dysfunction19–21,23. Notably, ROS levels remained elevated even after 24 h of re-exposure to normal gravity (Fig. 1B). This persistent ROS elevation may reflect a short-term endothelial “memory” of simulated microgravity exposure, in which redox homeostasis does not normalize immediately after return to standard gravity. From a physiological perspective, such persistence raises the possibility of a transient window of vascular vulnerability during early recovery or readaptation phases after gravitational transition. However, this interpretation remains hypothesis-generating, because the present study was performed in a short-term in vitro HUVEC model and does not directly establish persistent endothelial dysfunction or post-flight vascular risk in astronauts. Mechanistically, our pharmacological and biochemical data support the presence of a prominent NOX-sensitive, superoxide-associated component under μG. DPI, a broad flavoprotein inhibitor widely used to inhibit NOX activity51,52, produced a directionally similar attenuation of μG-induced ROS (Fig. 5). In parallel, MCLA chemiluminescence, used here as a superoxide-associated readout, increased under μG and was suppressed by both resveratrol and DPI (Fig. 6), while PMA, used as an assay-validating NOX-activating positive control65–67, confirmed the responsiveness of the MCLA system. Collectively, these observations are consistent with NOX enzymes contributing substantially to μG-triggered redox dysregulation. Nonetheless, given the off-target actions of DPI on multiple flavoproteins, our data should not be interpreted as definitive proof that all of the oxidative stress is generated exclusively by NOX; rather, they support a model in which a NOX-sensitive component makes a major contribution, while additional oxidant sources, including flavin-dependent mitochondrial ROS, cannot yet be excluded. In this context, the protective effect of resveratrol may reflect not only attenuation of NOX-linked superoxide generation, but also direct or indirect modulation of mitochondrial ROS and enhancement of endogenous antioxidant defenses, including SOD- and GPx-related pathways100. These possibilities were not directly dissected in the present study and should therefore be considered complementary, non-mutually exclusive mechanisms. Functionally, μG decreased cell number and altered monolayer morphology (Fig. 7), with trypan blue counts confirming a significant reduction in viable cells (Fig. 8). Resveratrol mitigated these μG-induced changes, in line with its ability to attenuate intracellular ROS accumulation (Fig. 2), partially re-establish the glutathione redox balance (Fig. 3), and reduce protein oxidation (Fig. 4). Notably, resveratrol also modestly increased cell number under normal gravity conditions. Although the present study was not designed to define the proliferative actions of resveratrol under basal 1G culture conditions, this finding is consistent with our previous work showing that low-dose resveratrol, including 1 µM, can enhance DNA synthesis and survival-related signaling in HUVECs, in contrast to the pro-oxidant and cytotoxic effects observed at higher concentrations40. The originality of the present work lies not in reaffirming the well-established contribution of oxidative stress to μG-induced endothelial dysfunction11,12,19,26,32,33,94, but in delivering an integrated characterization of this response in a single endothelial model using complementary biochemical, redox, and functional endpoints. Moreover, to the best of our knowledge, this is the first study to examine resveratrol under simulated microgravity in relation to a prominent NOX-sensitive oxidative component in endothelial cells. Our data support the involvement of a prominent NOX-sensitive superoxide-associated component in the oxidative stress induced by simulated μG. Specifically, μG exposure produced a coherent oxidative phenotype in HUVECs, including increased intracellular ROS (Figs. 1 and 2), persistence of oxidative imbalance after return to normal gravity (Fig. 1B), disruption of glutathione redox homeostasis, as reflected by a reduced GSH/GSSG ratio (Fig. 3), and increased oxidative protein damage, as indicated by protein carbonyl accumulation (Fig. 4). In this context, the attenuation of the ROS signal by DPI (Fig. 5), together with the increase in MCLA-detectable superoxide-associated chemiluminescence under μG and its reduction by both DPI and resveratrol (Fig. 6), supports the presence of a prominent NOX-sensitive component within the broader endothelial redox response. The parallel effects of DPI and resveratrol further support the working hypothesis that resveratrol attenuates not only oxidative burden itself, but also a NOX-sensitive oxidative component, either through partial interference with NOX-linked superoxide generation or through modulation of upstream and downstream redox-sensitive mechanisms. Notably, these redox alterations were accompanied by morphological changes and a reduction in viable cell number (Figs. 7, 8), thereby linking oxidative stress to a measurable loss of endothelial homeostasis. Taken together, these findings position resveratrol not merely as a generic antioxidant, but as a redox-active intervention capable of significantly attenuating the endothelial oxidative phenotype induced by simulated μG. Our results carry translational implications. Overactivation of NOX enzymes and the resulting oxidative stress are implicated in human vascular pathologies, including atherosclerosis, hypertension, diabetes, and neurodegenerative disease, each characterized by endothelial dysfunction[54,101–103]. By attenuating a NOX-sensitive ROS-associated component and partially restoring glutathione redox balance, resveratrol may provide therapeutic benefit in such conditions, extending its relevance beyond space medicine. Nevertheless, some limitations of our study warrant further investigation. First, we focused on a short-term exposure (24 h), which may not fully reflect the chronic effects of μG experienced during extended missions. Second, the study was limited to a single endothelial cell type (HUVECs); other endothelial subtypes (e.g., microvascular or arterial endothelial cells) may respond differently. In addition, dedicated dose–response and time-course experiments under simulated μG conditions were not performed; therefore, the concentrations used here should be interpreted as literature- and experience-based working concentrations rather than as formally optimized doses for maximal protection under simulated microgravity. Similarly, resveratrol and DPI were not tested under time-matched pretreatment conditions, which precludes a formal comparison of their relative pharmacodynamic efficacy. The comparison between the two compounds should therefore be interpreted primarily in mechanistic terms, as evidence that both interventions attenuate a NOX-sensitive/NADPH-dependent superoxide-associated component, rather than as evidence of equivalent kinetics or identical mechanisms of action. Additionally, the bioavailability and pharmacokinetics of resveratrol under spaceflight conditions remain to be validated in vivo using appropriate models. Finally, further studies should explore whether the protective effects of resveratrol involve key redox-regulated pathways, such as Nrf2-mediated antioxidant responses or SIRT1 activation, and whether these pathways can be enhanced through combination therapies with other targeted antioxidants. In conclusion, our data show that simulated μG induces a marked oxidative disturbance in endothelial cells and that resveratrol significantly attenuates this response. Although additional oxidant sources cannot yet be excluded, taken together, the current pharmacological and biochemical findings support the presence of a prominent NOX-sensitive, superoxide-associated component that contributes significantly to oxidative stress induced by simulated μG. By limiting ROS accumulation, protein oxidation, glutathione imbalance, superoxide-associated MCLA signaling, and loss of viable cell number, resveratrol significantly attenuates simulated microgravity-induced oxidative stress and redox imbalance in endothelial cells, including a prominent NOX-sensitive component. These findings do not establish NOX as the exclusive source of ROS, nor do they define resveratrol as a selective NOX-targeting intervention, but they strongly support the potential of resveratrol as a redox-active countermeasure under spaceflight-relevant conditions. Author contributions Conceptualization, R.G. and G.P; methodology, R.G., S.C., A.M.P, P.M. and A.M.; formal analysis R.G., S.C., A.M.P, P.M. and A.M.; investigation R.G., C.S. A.M. and G.P.; resource R.G., A.P. and G.P.; data curation R.G. and G.P.; writing-original draft preparation R.G., C.S. and G.P.; writing-review and editing R.G., A.P. and G.P.; supervision G.P. All authors have read and agreed to the published version of the manuscript. Funding This work has been developed within the framework of the project eINS-Ecosystem of Innovation for Next Generation Sardinia (cod. ECS 00000038), funded by the Italian Ministry for Research and Education (MUR) under the National Recovery and Resilience Plan (PNRR). This work was also made possible thanks to “Progetto Fondazione di Sardegna -Bando 2022–2023” and “DM 737/2021 resources 2021–2022, funded by the European Union—NextGenerationEU.” Data availability All data generated or analyzed during this study are included in this published article and its Supplementary Information files. Competing interests I declare that the authors have no competing interests as defined by Nature Research, or other interests that might be perceived to influence the results and/or discussion reported in this paper. Dual publication The results/data/figures in this manuscript have not been published elsewhere, nor are they under consideration by another publisher. The authors declare they have no conflict of interest. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Roberta Giordo, Email: roberta.giordo@uniroma5.it. Antonella Pantaleo, Email: apantaleo@uniss.it. Gianfranco Pintus, Email: gpintus@uniss.it. References Associated Data Data Citations Data Availability Statement All data generated or analyzed during this study are included in this published article and its Supplementary Information files.